Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 13, 2020 Filed Jan 15, 2020 21:08 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 300 $227.56 $68,268.00
Disclosure

SEC source: 0001209191-20-003457 · doc4.xml · nonDerivative · entry 4

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,303

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $227.56 (range $227.53 to $227.62).

Read SEC document
January 13, 2020 Filed Jan 15, 2020 21:08 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 1,225 $226.42 $277,364.50
Disclosure

SEC source: 0001209191-20-003457 · doc4.xml · nonDerivative · entry 3

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,603

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $226.42 (range $226.06 to $227.01).

Read SEC document
January 13, 2020 Filed Jan 15, 2020 21:08 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 300 $225.27 $67,581.00
Disclosure

SEC source: 0001209191-20-003457 · doc4.xml · nonDerivative · entry 2

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,828

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $225.27 (range $224.75 to $225.57).

F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
January 13, 2020 Filed Jan 15, 2020 21:08 UTC
Parini MichaelEVP, CL&AO
Exercise / conversionCommon Stock 2,125 $90.29 $191,866.25
Disclosure

SEC source: 0001209191-20-003457 · doc4.xml · nonDerivative · entry 1

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,128

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 13, 2020 Filed Jan 15, 2020 21:09 UTC
Silva Paul MSVP & Controller
Exercise / conversionStock Option (Right to Buy) · Derivative 860 $0.00 Strike: $90.29 $0.00
Disclosure

SEC source: 0001209191-20-003458 · doc4.xml · derivative · entry 4

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,719

Underlying: Common Stock · 860 shares

Expires 2026-07-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/12/2016.

Read SEC document
January 13, 2020 Filed Jan 15, 2020 21:09 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 860 $229.38 $197,266.80
Disclosure

SEC source: 0001209191-20-003458 · doc4.xml · nonDerivative · entry 2

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,759

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

Read SEC document
January 13, 2020 Filed Jan 15, 2020 21:09 UTC
Silva Paul MSVP & Controller
Exercise / conversionCommon Stock 860 $90.29 $77,649.40
Disclosure

SEC source: 0001209191-20-003458 · doc4.xml · nonDerivative · entry 1

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 08, 2020 Filed Jan 10, 2020 21:22 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,675 $0.00 Strike: $187.53 $0.00
Disclosure

SEC source: 0001209191-20-003055 · doc4.xml · derivative · entry 3

Tatsis Ourania · CIK 0001789815 · SVP, CRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,263

Underlying: Common Stock · 1,675 shares

Expires 2029-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/6/2019.

Read SEC document
January 08, 2020 Filed Jan 10, 2020 21:22 UTC SaleCommon Stock 1,675 $227.53 $381,112.75
Disclosure

SEC source: 0001209191-20-003055 · doc4.xml · nonDerivative · entry 2

Tatsis Ourania · CIK 0001789815 · SVP, CRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,252

F1 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1.

Read SEC document
January 08, 2020 Filed Jan 10, 2020 21:22 UTC Exercise / conversionCommon Stock 1,675 $187.53 $314,112.75
Disclosure

SEC source: 0001209191-20-003055 · doc4.xml · nonDerivative · entry 1

Tatsis Ourania · CIK 0001789815 · SVP, CRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,927

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 08, 2020 Filed Jan 10, 2020 21:32 UTC
Silva Paul MSVP & Controller
Exercise / conversionStock Option (Right to Buy) · Derivative 13,750 $0.00 Strike: $131.89 $0.00
Disclosure

SEC source: 0001209191-20-003064 · doc4.xml · derivative · entry 4

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,750 shares

Expires 2025-07-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fully vested.

Read SEC document
January 08, 2020 Filed Jan 10, 2020 21:32 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 13,750 $231.89 $3,188,487.50
Disclosure

SEC source: 0001209191-20-003064 · doc4.xml · nonDerivative · entry 2

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,759

F1 · kind: Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $231.89 (range $231.89 to $231.90).

F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
January 08, 2020 Filed Jan 10, 2020 21:32 UTC
Silva Paul MSVP & Controller
Exercise / conversionCommon Stock 13,750 $131.89 $1,813,487.50
Disclosure

SEC source: 0001209191-20-003064 · doc4.xml · nonDerivative · entry 1

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 08, 2020 Filed Jan 10, 2020 21:46 UTC
Sachdev AmitEVP, Chief Patient Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $109.14 $0.00
Disclosure

SEC source: 0001209191-20-003079 · doc4.xml · derivative · entry 5

Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 5,000 shares

Expires 2025-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested.

Read SEC document
January 08, 2020 Filed Jan 10, 2020 21:46 UTC
Sachdev AmitEVP, Chief Patient Officer
SaleCommon Stock 5,000 $230.00 $1,150,000.00
Disclosure

SEC source: 0001209191-20-003079 · doc4.xml · nonDerivative · entry 2

Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,190

F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.

Read SEC document
January 08, 2020 Filed Jan 10, 2020 21:46 UTC
Sachdev AmitEVP, Chief Patient Officer
Exercise / conversionCommon Stock 5,000 $109.14 $545,700.00
Disclosure

SEC source: 0001209191-20-003079 · doc4.xml · nonDerivative · entry 1

Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:11 UTC
Parini MichaelEVP, CL&AO
Exercise / conversionStock Option (Right to Buy) · Derivative 4,250 $0.00 Strike: $122.45 $0.00
Disclosure

SEC source: 0001209191-20-002501 · doc4.xml · derivative · entry 8

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,250 shares

Expires 2026-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: Fully vested.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:11 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 329 $224.11 $73,732.19
Disclosure

SEC source: 0001209191-20-002501 · doc4.xml · nonDerivative · entry 7

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,003

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F8 · price: Open market sales reported on this line occurred at a weighted average price of $224.11 (range $224.02 to $224.27).

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:11 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 1,063 $223.60 $237,686.80
Disclosure

SEC source: 0001209191-20-002501 · doc4.xml · nonDerivative · entry 6

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,332

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $223.60 (range $223.19 to $223.99).

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:11 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 398 $222.67 $88,622.66
Disclosure

SEC source: 0001209191-20-002501 · doc4.xml · nonDerivative · entry 5

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,395

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $222.67 (range $222.14 to $222.99).

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:11 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 1,599 $221.49 $354,162.51
Disclosure

SEC source: 0001209191-20-002501 · doc4.xml · nonDerivative · entry 4

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,793

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $221.49 (range $221.00 to $221.82).

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:11 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 461 $220.69 $101,738.09
Disclosure

SEC source: 0001209191-20-002501 · doc4.xml · nonDerivative · entry 3

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,392

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $220.69 (range $220.32 to $220.99).

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:11 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 400 $218.93 $87,572.00
Disclosure

SEC source: 0001209191-20-002501 · doc4.xml · nonDerivative · entry 2

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,853

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $218.93 (range $218.40 to $219.37).

F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:11 UTC
Parini MichaelEVP, CL&AO
Exercise / conversionCommon Stock 4,250 $122.45 $520,412.50
Disclosure

SEC source: 0001209191-20-002501 · doc4.xml · nonDerivative · entry 1

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,253

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
Exercise / conversionStock Option (Right to buy) · Derivative 2,427 $0.00 Strike: $86.52 $0.00
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · derivative · entry 13

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,045

Underlying: Common Stock · 2,427 shares

Expires 2027-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
Exercise / conversionStock Option (Right to buy) · Derivative 2,578 $0.00 Strike: $90.29 $0.00
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · derivative · entry 12

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,579

Underlying: Common Stock · 2,578 shares

Expires 2026-07-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/12/2016.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
Exercise / conversionStock Option (Right to buy) · Derivative 3,867 $0.00 Strike: $91.05 $0.00
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · derivative · entry 11

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,290

Underlying: Common Stock · 3,867 shares

Expires 2026-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
Exercise / conversionStock Option (Right to buy) · Derivative 16,758 $0.00 Strike: $109.14 $0.00
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · derivative · entry 10

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,758 shares

Expires 2025-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 100 $220.07 $22,007.00
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · nonDerivative · entry 8

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,759

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 12,648 $219.37 $2,774,591.76
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · nonDerivative · entry 7

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,859

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $219.37 (range $219.07 to $219.82).

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 10,040 $218.70 $2,195,748.00
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · nonDerivative · entry 6

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,507

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $218.70 (range $218.07 to $219.06).

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 2,842 $217.68 $618,646.56
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · nonDerivative · entry 5

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,547

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $217.68 (range $217.08 to $218.02).

F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
Exercise / conversionCommon Stock 2,427 $86.52 $209,984.04
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · nonDerivative · entry 4

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,389

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
Exercise / conversionCommon Stock 2,578 $90.29 $232,767.62
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · nonDerivative · entry 3

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,962

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
Exercise / conversionCommon Stock 3,867 $91.05 $352,090.35
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · nonDerivative · entry 2

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,384

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:17 UTC
Silva Paul MSVP & Controller
Exercise / conversionCommon Stock 16,758 $109.14 $1,828,968.12
Disclosure

SEC source: 0001209191-20-001770 · doc4.xml · nonDerivative · entry 1

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,517

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:18 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $72.14 $0.00
Disclosure

SEC source: 0001209191-20-001775 · doc4.xml · derivative · entry 6

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2024-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:18 UTC SaleCommon Stock 100 $220.08 $22,008.00
Disclosure

SEC source: 0001209191-20-001775 · doc4.xml · nonDerivative · entry 5

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,311

F1 · kind: Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:18 UTC SaleCommon Stock 10,134 $219.37 $2,223,095.58
Disclosure

SEC source: 0001209191-20-001775 · doc4.xml · nonDerivative · entry 4

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,411

F1 · kind: Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $219.37 (range $219.08 to $219.78).

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:18 UTC SaleCommon Stock 7,266 $218.73 $1,589,292.18
Disclosure

SEC source: 0001209191-20-001775 · doc4.xml · nonDerivative · entry 3

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,545

F1 · kind: Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $218.73 (range $218.08 to $219.07).

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:18 UTC SaleCommon Stock 2,500 $217.72 $544,300.00
Disclosure

SEC source: 0001209191-20-001775 · doc4.xml · nonDerivative · entry 2

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,811

F1 · kind: Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $217.72 (range $217.08 to $218.06).

F3 · price: Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:18 UTC Exercise / conversionCommon Stock 20,000 $72.14 $1,442,800.00
Disclosure

SEC source: 0001209191-20-001775 · doc4.xml · nonDerivative · entry 1

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,311

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 30, 2019 Filed Jan 2, 2020 21:21 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $65.65 $0.00
Disclosure

SEC source: 0001209191-20-000298 · doc4.xml · derivative · entry 6

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2024-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
December 30, 2019 Filed Jan 2, 2020 21:21 UTC SaleCommon Stock 300 $221.16 $66,348.00
Disclosure

SEC source: 0001209191-20-000298 · doc4.xml · nonDerivative · entry 5

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,311

F1 · kind: Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $221.16 (range $221.09 to $221.30).

Read SEC document
December 30, 2019 Filed Jan 2, 2020 21:21 UTC SaleCommon Stock 500 $220.25 $110,125.00
Disclosure

SEC source: 0001209191-20-000298 · doc4.xml · nonDerivative · entry 4

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,611

F1 · kind: Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $220.25 (range $219.90 to $220.73).

Read SEC document
December 30, 2019 Filed Jan 2, 2020 21:21 UTC SaleCommon Stock 21,798 $218.93 $4,772,236.14
Disclosure

SEC source: 0001209191-20-000298 · doc4.xml · nonDerivative · entry 3

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,111

F1 · kind: Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $218.93 (range $218.50 to $219.47).

Read SEC document
December 30, 2019 Filed Jan 2, 2020 21:21 UTC SaleCommon Stock 7,402 $218.05 $1,614,006.10
Disclosure

SEC source: 0001209191-20-000298 · doc4.xml · nonDerivative · entry 2

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,909

F1 · kind: Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $218.05 (range $217.50 to $218.49).

F3 · price: Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
December 30, 2019 Filed Jan 2, 2020 21:21 UTC Exercise / conversionCommon Stock 30,000 $65.65 $1,969,500.00
Disclosure

SEC source: 0001209191-20-000298 · doc4.xml · nonDerivative · entry 1

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,311

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 09, 2019 Filed Dec 10, 2019 21:49 UTC
Sachdev AmitEVP, Chief Patient Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $109.14 $0.00
Disclosure

SEC source: 0001209191-19-059883 · doc4.xml · derivative · entry 5

Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,500

Underlying: Common Stock · 5,000 shares

Expires 2025-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
December 09, 2019 Filed Dec 10, 2019 21:49 UTC
Sachdev AmitEVP, Chief Patient Officer
SaleCommon Stock 5,000 $225.00 $1,125,000.00
Disclosure

SEC source: 0001209191-19-059883 · doc4.xml · nonDerivative · entry 2

Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,416

F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.